SensiScreen® FFPE BRAF qPCR Assay

The EpiDirect® MGMT Methylation qPCR Assay represents a new and innovative approach allowing for direct quantification of MGMT promoter methylation by qPCR without prior DNA conversion.

The EpiDirect® technology is based on our unique INA® chemistry and includes an EpiPrimer™ oligonucleotide that specifically binds and primes amplification of methylated target DNA.

The assay is able to quantify MGMT promoter methylation using standard real-time PCR instruments* in just two hours with as little as 0.5 ng of unconverted input DNA.

  • Standard qPCR instrument procedure
  • No need for prior conversion of DNA
  • Results in less than 2 hours
  • 1.5-3% LoD methylation
  • Minimal hands-on time
  • 0.5-50 ng input DNA
  • CE IVD

*Validated on CFX96/CFX Opus 96 (Bio-Rad), QuantStudio™5 (ABI) and BaseTyper™ 48.4 (PentaBase) Real-Time PCR Systems

Product Details

Reference Number                                                   8300

Product Name                                                           EpiDirect® MGMT Methylation qPCR Assay

Product Description                                                 PCR master mix and oligonucleotide mix for quantification of MGMT promoter methylation, positive and negative control

Format                                                                        Ready-to-Use

Reactions                                                                   48

List Price                                                                     €2640 / DKK19.668

Intended Use

EpiDirect® MGMT Methylation qPCR Assay is a semi-automated real-time Polymerase Chain Reaction (PCR) assay intended for the direct, semi-quantitative analysis of the methylation status of the human DNA repair enzyme O6-methylguanine-DNA methyltransferase (MGMT) gene promoter.

The assay is intended for analysis of purified genomic DNA (gDNA) samples that without further pre-treatment can be used with real-time PCR systems for the detection and quantification of the methylation status of the MGMT promoter. Samples comprise Formalin-Fixed Paraffin-Embedded (FFPE) and fresh frozen biopsies and can be prepared using automated platforms or manual workflows.

EpiDirect® MGMT Methylation qPCR Assay is intended for use by health professionals or qualified laboratory personnel specifically instructed and trained in the techniques of Real-Time PCR as well as proficient in handling biological samples. Medical interventions based on results from this product requires medical authorization.

Product Specifications

Procedure                                                                  Real-time PCR-based

Validated Real-Time PCR instruments                 BaseTyper™ 48.4 Quiet HRM (PentaBase Ref. No. 754), CFX96 and CFX Opus 96 (Bio-Rad) and QuantStudio™ 5 Real-Time PCR Systems

PentaBase technologies                                         EpiPrimer™, HydrolEasy® Probe, and SuPrimer™

Genomic target                                                         DMR2 region CpG sites 75-78 in exon 1 of the MGMT promoter

Sample types                                                            Solid glioblastoma biopsies including formalin-fixed paraffin-embedded (FFPE) tissue samples

Sample tumor cell percentage                               At least 20%

Sample DNA extraction methods                          Relevant commercially avaliable solid biospy/FFPE DNA extraction kits

Sample input                                                             0.1-10 ng/µL of purified DNA directly from the sample that has not been otherwise chemically manipulated

PCR run time                                                             Less than 2 hours

Instructions For Use

The latest version of the Instructions For Use can be found at: www.5ba.se/ED001

Publications

A qPCR technology for direct quantification of methylation in untreated DNA

Bendixen et al. – Nature Communications – 2023

Read article

Related files

File
File name
Size
pdf
Data sheet
EpiDirect_MGMT_MSDS.pdf
210 KB
pdf
EpiDirect_MGMT_Flyer.pdf

A Revolutionary Approach to DNA Methylation Testing

Current methods for evaluating DNA methylation are relying on sodium bisulfite or other chemical or enzymatical conversion of cytosines. However, variability in conversion rates as well as DNA degradation resulting from chemical treatment may lead to false or in-conclusive results. Especially bisulfite treatments have been shown to lead to a biased degradation of unmethylated DNA and consequently an overestimation of the methylation frequency.  

In contrast, the EpiDirect® technology allows for direct quantification of DNA methylation by PCR without any prior chemical or enzymatic treatment. This revolutionizing technology not only eliminates artefacts related to incomplete conversion of cytosines and DNA degradation but also vastly reduces hands-on-time and time to result.

The EpiDirect® Technology

The EpiDirect® technology is based on a unique DNA analogue chemistry known as intercalating pseudo-nucleotide (IPN). IPN-containing oligonucleotides, also known as intercalating nucleic acids (INAs®), show highly improved target affinity and specificity compared to standard chemistry oligonucleotides.

The EpiDirect® technology utilizes a type of INA® known as an EpiPrimer™ that selectively binds to and primes amplification of methylated DNA. The EpiPrimer™ consists of 3 parts: a) an IPN-containing anchor sequence that binds to the methylated target region, b) a starter sequence that primes DNA replication, and c) a loop sequence that is part of the subsequent methyl-unspecific priming. Thus, the anchor and starter sequence prime the initial replication of the methylated DNA while the loop and starter sequence combined work as a primer in the remaining PCR cycles.

INA®-based IVD PCR assays with superior performances

Our IVD PCR assays are based on a unique INA® oligonucleotide chemistry with superior target affinity and specificity. The INA®-based IVD PCR assay portfolio including SensiScreen®, PlentiPlex™ and EpiDirect® product families offer excellent performances, are easy to implement in standard laboratory workflows and provide results in a couple of hours.

Tilføj venligst et billede!

Related products

MicroSight MSI_old
Microsatellite instability
SensiScreen® Liquid
Somatic cancer mutations
PlentiPlex MYD88_old
MYD88/Waldenström Lymphoma

Get in contact